Chattanooga Research and Medicine CHARM

Chattanooga, Tennessee 37404-3230

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease, Clostridioides Difficile Infection, Diabetes Mellitus, Type 2, Dyslipidemia, High Cardiovascular Risk, Obesity, Overweight, Type 2 Diabetes, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection — Completed
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed